Title |
Emotion dysregulation as a transdiagnostic mechanism of opioid misuse and suicidality among chronic pain patients
|
---|---|
Published in |
Borderline Personality Disorder and Emotion Dysregulation, June 2018
|
DOI | 10.1186/s40479-018-0088-6 |
Pubmed ID | |
Authors |
Michael R. Riquino, Sarah E. Priddy, Matthew O. Howard, Eric L. Garland |
Abstract |
Chronic pain is a prevalent condition that causes functional impairment and emotional suffering. To allay pain-induced suffering, opioids are often prescribed for chronic pain management. Yet, chronic pain patients on opioid therapy are at heightened risk for opioid misuse-behaviors that can lead to addiction and overdose. Relatedly, chronic pain patients are at elevated risk for suicidal ideation and suicidal behaviors. Opioid misuse and suicidality are maladaptive processes aimed at alleviating the negative emotional hyperreactivity, hedonic hyporeactivity, and emotion dysregulation experienced by chronic pain patients on opioid therapy. In this review, we explore the role of emotion dysregulation in chronic pain. We then describe why emotionally dysregulated chronic pain patients are vulnerable to opioid misuse and suicidality in response to these negative affective states. Emotion dysregulation is an important and malleable treatment target with the potential to reduce or prevent opioid misuse and suicidality among opioid-treated chronic pain patients. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 73 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 12 | 16% |
Student > Bachelor | 11 | 15% |
Student > Doctoral Student | 6 | 8% |
Other | 6 | 8% |
Student > Master | 6 | 8% |
Other | 11 | 15% |
Unknown | 21 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Psychology | 21 | 29% |
Neuroscience | 9 | 12% |
Medicine and Dentistry | 9 | 12% |
Nursing and Health Professions | 4 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
Other | 3 | 4% |
Unknown | 25 | 34% |